Cargando…
Randomized, Placebo-Controlled, Double-Blind and Open-Label Studies in the Treatment and Prevention of Acute Diarrhea With Enterococcus faecium SF68
Enterococcus faecium SF68® (SF68) is a licensed pharmaceutical for treatment and prevention of diarrhea in Austria, Italy and Switzerland. However, as for other probiotics, evidence for its efficacy is based on small to medium-sized studies. Four unpublished studies on the treatment of acute diarrhe...
Autores principales: | Greuter, Thomas, Michel, Martin C., Thomann, Daniela, Weigmann, Harald, Vavricka, Stephan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326027/ https://www.ncbi.nlm.nih.gov/pubmed/32656217 http://dx.doi.org/10.3389/fmed.2020.00276 |
Ejemplares similares
-
Effect of probiotic Enterococcus faecium SF68 on liver function in healthy dogs
por: Lucena, Rosario, et al.
Publicado: (2019) -
The administration of Enterococcus faecium SF68 counteracts compositional shifts in the gut microbiota of diet-induced obese mice
por: Panattoni, Adelaide, et al.
Publicado: (2022) -
Effect of short-term probiotic Enterococcus faecium SF68 dietary supplementation in overweight and obese cats without comorbidities
por: Kathrani, Aarti, et al.
Publicado: (2016) -
A virulence factor as a therapeutic: the probiotic Enterococcus faecium SF68 arginine deiminase inhibits innate immune signaling pathways
por: Ghazisaeedi, Fereshteh, et al.
Publicado: (2022) -
Replacement of Enterococcus faecalis by Enterococcus faecium as the predominant enterococcus in UK bacteraemias
por: Horner, Carolyne, et al.
Publicado: (2021)